Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Ligusticum Porteri Root, also known as Osha, is a botanical substance classified primarily as a Non-Standardized Plant Allergenic Extract used in diagnostic testing and immunotherapy for allergic sensitivities.
Name
Ligusticum Porteri Root
Raw Name
LIGUSTICUM PORTERI ROOT
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
6
Variant Count
6
Last Verified
February 17, 2026
About Ligusticum Porteri Root
Ligusticum Porteri Root, also known as Osha, is a botanical substance classified primarily as a Non-Standardized Plant Allergenic Extract used in diagnostic testing and immunotherapy for allergic sensitivities.
Detailed information about Ligusticum Porteri Root
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Ligusticum Porteri Root.
Ligusticum Porteri Root, commonly referred to in botanical circles as Osha Root or 'Bear Medicine,' is a perennial herb native to the Rocky Mountains and the Sierra Madre. In a clinical and regulatory context, Ligusticum Porteri Root belongs to a class of drugs called Non-Standardized Plant Allergenic Extracts [EPC]. While it has a long history of use in indigenous North American medicine, its primary listing in modern clinical databases refers to its role as an allergenic extract used by allergists and immunologists to diagnose or treat hypersensitivity reactions to specific plant proteins.
According to the FDA's Center for Biologics Evaluation and Research (CBER), non-standardized extracts like Ligusticum Porteri Root are utilized in skin testing (diagnostic) and allergen-specific immunotherapy (therapeutic). The classification of this substance is complex, as it is also associated with categories such as Standardized Chemical Allergen [EPC], Non-Standardized Fungal Allergenic Extract [EPC], and Non-Standardized Food Allergenic Extract [EPC]. Interestingly, it is sometimes listed under the Vitamin C [EPC] class in specific multi-ingredient contexts, though its primary pharmacological identity remains that of a plant-derived biological substance.
Historically, Ligusticum Porteri has not undergone the same rigorous FDA New Drug Application (NDA) process as synthetic pharmaceuticals like lisinopril or atorvastatin. Instead, many allergenic extracts were 'grandfathered' into the market or are regulated under Biologics License Applications (BLAs). Patients should understand that 'non-standardized' means the potency of the extract is not measured by a federally mandated bioassay, but rather by the weight/volume (w/v) of the source material or by Protein Nitrogen Unit (PNU) content.
The mechanism of action for Ligusticum Porteri Root depends entirely on its clinical application. When used as a diagnostic allergenic extract, the substance works through an IgE-mediated hypersensitivity reaction. When a small amount of the extract is introduced into the skin (via prick or intradermal injection), the plant proteins cross-link with specific Immunoglobulin E (IgE) antibodies bound to the surface of mast cells and basophils. This cross-linking triggers degranulation, releasing histamine and other inflammatory mediators, which results in a 'wheal and flare' reaction (a raised bump and redness). This allows the healthcare provider to confirm a patient's sensitivity to the plant.
In the context of Allergen Immunotherapy (AIT), the mechanism is more complex. By exposing the patient to gradually increasing doses of the Ligusticum Porteri extract, the immune system undergoes 'desensitization.' At the molecular level, this involves:
From a traditional pharmacological perspective, the root contains various bioactive compounds, most notably phthalides (such as Z-ligustilide), ferulic acid, and terpenoids. In laboratory settings, these compounds have shown potential anti-inflammatory and bronchodilatory properties, though these are not currently the basis for its FDA-recognized use as an allergenic extract.
Because Ligusticum Porteri Root is typically administered topically (for testing) or via subcutaneous injection (for immunotherapy), its pharmacokinetic profile differs significantly from oral medications.
The primary clinical indications for Ligusticum Porteri Root extracts include:
Ligusticum Porteri Root is available in several forms, depending on the intended use:
> Important: Only your healthcare provider can determine if Ligusticum Porteri Root is right for your specific condition. The use of allergenic extracts must be conducted under the supervision of a physician trained in the management of anaphylaxis.
Dosage for Ligusticum Porteri Root as an allergenic extract is highly individualized and must be determined by an allergist. There is no 'standard' dose for all patients.
Ligusticum Porteri Root extracts can be used in children, but extreme caution is required.
No specific dose adjustments are provided for renal impairment, as the systemic absorption of the allergenic proteins is minimal. However, the patient's overall health must be considered.
No specific adjustments are required for hepatic impairment. The metabolism of these proteins is not primarily dependent on the cytochrome P450 system.
Elderly patients may be at higher risk for complications if a systemic reaction occurs (e.g., due to pre-existing cardiovascular disease). Healthcare providers may use lower starting doses or a slower build-up phase for patients over 65.
Clinical extracts of Ligusticum Porteri Root must NEVER be self-administered at home. They must be administered in a medical facility equipped with emergency supplies (epinephrine, oxygen, IV fluids).
If a dose of immunotherapy is missed, the next dose may need to be reduced depending on how much time has passed.
An 'overdose' in the context of allergenic extracts usually refers to an injection of a dose higher than the patient's current tolerance level, which can lead to a severe systemic reaction.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or the frequency of your injections without medical guidance.
Most patients receiving Ligusticum Porteri Root extracts for testing or therapy will experience local reactions. These are generally not dangerous but can be uncomfortable.
> Warning: Stop taking Ligusticum Porteri Root and call your doctor immediately if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' effects of Ligusticum Porteri Root when used as an allergenic extract. The primary long-term effect is the intended modification of the immune system. However, patients with underlying autoimmune conditions should be monitored, as there is a theoretical (though unproven) risk that chronic immune stimulation could affect their condition.
While Ligusticum Porteri Root specifically may not have an individual black box warning, the class of Allergenic Extracts carries a general warning regarding the risk of severe systemic reactions.
FDA Class Warning for Allergenic Extracts:
Report any unusual symptoms to your healthcare provider. Even a 'large' local reaction should be reported, as it may be a precursor to a systemic reaction at the next dose.
Ligusticum Porteri Root is a potent biological substance. It is not a 'natural' remedy in the sense of being harmless; it is designed to interact directly with your immune system. Patients must be honest with their doctors about their current health status, especially any respiratory or heart conditions, before receiving this extract.
No specific FDA black box warning exists solely for Ligusticum Porteri Root; however, it falls under the general safety mandate for all non-standardized allergenic extracts. This mandate requires administration in a clinical setting with a minimum 30-minute post-injection observation period. Failure to adhere to this protocol has resulted in fatalities due to delayed-onset anaphylaxis.
Most patients can drive after the 30-minute observation period. However, if you experience dizziness, fatigue, or 'brain fog' after your injection, avoid driving or operating heavy machinery until these symptoms resolve.
Alcohol can increase blood flow to the skin (vasodilation) and may potentially accelerate the absorption of the allergen or worsen a local reaction. It is recommended to avoid alcohol for several hours before and after an immunotherapy injection.
If you decide to stop immunotherapy, you can generally do so without a 'tapering' period, as there is no physical dependence. However, your allergy symptoms will likely return over time. If you stop for several months and wish to restart, you cannot return to your previous dose; you must start over at a lower concentration to avoid a severe reaction.
> Important: Discuss all your medical conditions with your healthcare provider before starting Ligusticum Porteri Root.
While there are few 'absolute' drug-drug contraindications, certain combinations significantly increase the risk of a poor outcome during a reaction:
For each major interaction, the management strategy usually involves either stopping the interfering medication (like antihistamines before testing) or conducting a thorough risk-benefit analysis (like with beta-blockers and immunotherapy).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Ligusticum Porteri Root extracts must NEVER be used in the following situations:
Conditions requiring careful risk-benefit analysis include:
Patients who are allergic to other members of the Apiaceae (Umbelliferae) family may experience cross-allergic reactions. This includes:
If you have a known severe allergy to celery, you must inform your doctor before being tested with Ligusticum Porteri Root.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Ligusticum Porteri Root.
Ligusticum Porteri Root is classified as Category C (using the older FDA system). There are no adequate and well-controlled studies in pregnant women.
It is not known whether the components of Ligusticum Porteri Root extract are excreted in human milk. Because these are large proteins that would likely be digested in the infant's stomach, the risk to a nursing infant is considered very low. Immunotherapy is generally considered compatible with breastfeeding.
Patients over 65 may have a higher prevalence of cardiovascular disease, which increases the risk of complications from a systemic reaction. Additionally, elderly patients are more likely to be taking medications like beta-blockers or ACE inhibitors. A thorough cardiac evaluation is recommended for older adults before starting immunotherapy.
No dosage adjustments are needed for patients with kidney disease. However, if a patient is on dialysis, the timing of the injection should be coordinated with their dialysis schedule to ensure stability.
No dosage adjustments are required for patients with liver disease. The proteins in the extract are not metabolized by the liver in a way that would be affected by cirrhosis or hepatitis.
> Important: Special populations require individualized medical assessment. Always inform your specialist of any changes in your health status, such as becoming pregnant.
Ligusticum Porteri Root extract acts as an immunomodulator. In diagnostic use, it functions by cross-linking IgE antibodies on mast cells, triggering the release of pre-formed mediators like histamine, leukotrienes, and prostaglandins. This is a classic Type I hypersensitivity reaction.
In therapeutic use (immunotherapy), the mechanism involves the induction of immune tolerance. Repeated exposure to the allergen leads to:
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Topical) |
| Protein Binding | Minimal (primarily local action) |
| Half-life | Variable (Proteins degraded within hours/days) |
| Tmax | 30-60 minutes (systemic absorption of proteins) |
| Metabolism | Proteolysis (Protease enzymes) |
| Excretion | Renal (Metabolites) |
Ligusticum Porteri Root belongs to the Non-Standardized Plant Allergenic Extract [EPC] class. Related medications include extracts for Ragweed, Timothy Grass, and Oak Tree pollen. It is distinct from 'Standardized' extracts (like Grass or Dust Mite) which have a federally mandated potency unit (e.g., BAU/mL).
Common questions about Ligusticum Porteri Root
In clinical medicine, Ligusticum Porteri Root is primarily used as an allergenic extract for diagnosing and treating allergies. Healthcare providers use it in skin prick tests to determine if a patient is hypersensitive to the plant's proteins. If a sensitivity is confirmed, it may be used in 'allergy shots' (immunotherapy) to help desensitize the patient's immune system over time. While it has traditional uses for coughs and infections, these are not FDA-approved clinical indications. Always consult an allergist for its proper medical use.
The most common side effects are local reactions at the site of the skin test or injection. These include redness, itching, and a small raised bump known as a wheal. Some patients may also experience mild swelling that lasts for a few hours. These reactions are usually a normal sign that the immune system is interacting with the extract. However, any reaction larger than a few centimeters should be reported to your doctor before your next dose.
It is generally advised to avoid alcohol on the days you receive an injection of Ligusticum Porteri Root extract. Alcohol can cause your blood vessels to dilate, which might speed up the absorption of the allergen into your bloodstream, potentially increasing the risk of a systemic reaction. Furthermore, alcohol can mask the early symptoms of an allergic reaction, such as lightheadedness or flushing. To ensure maximum safety, wait at least 24 hours after your injection before consuming alcohol. Always follow the specific guidance provided by your allergy clinic.
The safety of starting Ligusticum Porteri Root immunotherapy during pregnancy has not been established. Most doctors will not begin this treatment for a pregnant patient because a severe allergic reaction could decrease oxygen flow to the baby or cause uterine contractions. However, if you are already on a stable maintenance dose and become pregnant, your doctor may decide it is safe to continue the treatment. You should inform your allergist immediately if you become pregnant or are planning to conceive. Each case requires a careful risk-benefit analysis by a medical professional.
When used for allergy testing, the results are almost immediate, usually appearing within 15 to 20 minutes. For immunotherapy (allergy shots), the process is much slower and requires patience. Most patients begin to feel a reduction in their allergy symptoms during the 'maintenance phase,' which typically occurs 3 to 6 months after starting treatment. Full effectiveness is usually reached after one year of consistent injections. Most experts recommend continuing the treatment for 3 to 5 years for long-lasting results.
Yes, you can stop receiving Ligusticum Porteri Root immunotherapy injections at any time without experiencing withdrawal symptoms. Unlike some medications that affect the nervous system, allergenic extracts do not cause physical dependence. However, stopping treatment before the recommended 3-to-5-year course is complete will likely result in the return of your allergy symptoms over time. If you miss several doses and then decide to restart, you must contact your doctor, as you will likely need to restart at a lower, safer dose to prevent a reaction.
If you miss a scheduled immunotherapy injection, contact your allergist's office to reschedule as soon as possible. The safety of your next dose depends on how much time has passed since your last injection. If you only miss a few days, your dose may remain the same. However, if you miss several weeks, your doctor will likely need to reduce the dose to ensure your immune system can still tolerate it safely. Never try to 'double up' on doses to make up for a missed one.
There is no clinical evidence to suggest that Ligusticum Porteri Root extracts, when used for testing or immunotherapy, cause weight gain. The amount of the substance administered is very small and does not affect the body's metabolic rate or appetite. If you experience unexpected weight gain while undergoing treatment, it is likely due to other factors, such as other medications (like oral steroids sometimes used for allergies) or changes in lifestyle. Discuss any concerns about weight with your healthcare provider.
Ligusticum Porteri Root can interact with certain medications, most notably beta-blockers and ACE inhibitors used for heart conditions. These drugs can make an allergic reaction more dangerous or harder to treat. Antihistamines will interfere with the accuracy of skin tests and must be stopped several days before testing. Most other routine medications, such as those for cholesterol or diabetes, do not interact with allergenic extracts. Always provide your doctor with a complete list of all medications and supplements you are currently taking.
The concept of 'generic' vs. 'brand name' is slightly different for allergenic extracts. Ligusticum Porteri Root is a biological product, and different manufacturers may produce their own versions of the extract. While they contain the same source material, they are 'non-standardized,' meaning the potency can vary between different suppliers. Therefore, extracts from different companies are not considered interchangeable. Your doctor will typically stick with one manufacturer's extract for the duration of your treatment to ensure consistent dosing.